Saravanan Muthupandian

40PUBLICATIONS
59CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Genetically modified field crops and pastureMolecular targetsGenomicsNanomedicine
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (40)

|May 26, 2026
Ethanolic extract of Otostegia fruticosa induces ROS-dependent apoptosis and reduces migration of MDA-MB-231 cells in vitro.

|Mar 16, 2026
Farm-Level Factors Associated With Multidrug-Resistant Escherichia coli and Klebsiella spp. in Bulk Tank Milk in Tigray, Northern Ethiopia.

Goyitom Gebremedhn Gebru, Saravanan Muthupandian, Enquebaher Kassaye

|Jan 26, 2026
Engineering combination nanomedicines to overcome cancer resistance.

Hina Singh, Sri Renukadevi Balusamy, Johan Sukweenadhi

|Dec 11, 2025
Exploring the genetic frontier: Unraveling ANRIL, PAI-1, and HNF1α in stroke progression.

Abdullah Hamadi, Rashid Mir, Osama M Al-Amer

|Nov 04, 2025
Smart hybrid nanomaterials for chronic infections: microbiome-responsive and sustainable therapeutic platforms.

Hina Singh, Sri Renukadevi Balusamy, Johan Sukweenadhi

|Sep 25, 2024
Green synthesis of cerium oxide nanoparticles usingTribulus terrestris: characterization and evaluation of antioxidant, anti-inflammatory and antibacterial efficacy against wound isolates.

Maganti Raghav Prasad Choudary, Muthuvel Surya, Muthupandian Saravanan

Pageof 7

Frequent Collaborators

5 joint publications

Yugal Kishore Mohanta

5 joint publications

Ragul Paramasivam

5 joint publications

Ranjithkumar Dhandapani

3 joint publications

Velmurugan Palanivel